학술논문

Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study
Document Type
Article
Source
In: Cancer Chemotherapy and Pharmacology. (Cancer Chemotherapy and Pharmacology, April 2024, 93(4):329-339)
Subject
Language
English
ISSN
14320843
03445704